Sign inJoin waitlistJoin the waitlist

Konstantin Dragnev

Interim Deputy Director and Associate Director for Clinical Research, NCCC · Geisel School of Medicine

Credentials: · · · ·

History

Hematology and Medical Oncology Section · Dartmouth Health
Present
Geisel School of Medicine
Present
Geisel School of Medicine
Present

Medical Oncology
1998–2000
Hematology Oncology
Memorial Sloan Kettering Cancer Center
1997–1998
Baylor College of Medicine Associated Hospitals
1993–1996
National Cancer Institute, National Institutes of Health
1992–1993
Bulgarian Medical Academy
1990–1991
District Hospital
1987–1989
Higher Institute of Medicine
1987

Research

Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial
Journal of Clinical Oncology · 2015 · 915 citations
Benefits of Early Versus Delayed Palliative Care to Informal Family Caregivers of Patients With Advanced Cancer: Outcomes From the ENABLE III Randomized Controlled Trial
Journal of Clinical Oncology · 2015 · 380 citations
MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors
Journal of Clinical Investigation · 2010 · 334 citations

ED
Ethan Dmitrovsky
26 papers
JR
James Rigas
19 papers
VM
Vincent Memoli
15 papers
Laura Tafe
11 papers
William Petty
11 papers · 9 as a fellow
GT
Gregory Tsongalis
10 papers
Keisuke Shirai
10 papers
Candice Black
7 papers
Jhanelle Gray
7 papers
David Gandara
6 papers
Fabrizio Galimberti
6 papers
Carl Morrison
5 papers

Grants

NCI National Clinical Trials Network - Network Lead Academic Participating Site (UG1)
National Cancer Institute · UG1
Contact PI · $2.5M · Dartmouth-Hitchcock Clinic
2019–2032
Cancer Center Support Grant
National Cancer Institute · P30
Contact PI · $5.1M · Dartmouth College
1997–2029
Dartmouth Lead Participation in NCI National Clinical Trials Network
National Cancer Institute · U10
Contact PI · $1.8M · Dartmouth-Hitchcock Clinic
2014–2019

Clinical trials

A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer
Principal investigator · Completed
Dartmouth-Hitchcock Medical Center
2009–2012
Study of Tarceva and Targretin in Stage I-II Lung Cancer
Principal investigator · Completed
Dartmouth-Hitchcock Medical Center
2005–2010
Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer
Principal investigator · Completed · Phase 2
Konstantin Dragnev
2005–2014
Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer
Principal investigator · Terminated · Phase 1, Phase 2
Konstantin Dragnev
2004–2009